The antibacterial medicine market in Germany is experiencing a consistent, albeit slow, growth. From the forecasted data, sales are expected to increase from 716.6 million Euros in 2024 to 719.8 million Euros by 2028, showing an incremental rise with minor year-on-year variations.

Despite the growth, the compound annual growth rate (CAGR) over this forecasting period remains low, indicating a stable market environment rather than one of volatility or rapid development.

Trends to watch for include:

Potential impacts of antibiotic resistance that might prompt increased innovation and sales volume.
Increasing regulatory scrutiny could either slow down the market or lead to shifts towards new antibacterial medicines.
Changes in public health strategies and antibiotic prescription practices could also alter future market dynamics.